VirTrial
APRIL 18, 2024
Study data is always subject to scrutiny by regulators, which further highlights its importance. Given the industry is a highly regulated one, there are always new regulations being issued. Given these regulations are not new, it is strange that industry has not prompted a complete solution to this already.
Outsourcing Pharma
APRIL 18, 2024
as a space where partners can come together to collaborate, innovate, and ideate on solutions to the biggest clinical supply chain pain points. Yesterday, Thermo Fisher Scientific opened its first Innovation Lab in Center Valley, Pennsylvania.,
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
MAY 24, 2023
Nearly every biopharma with a portfolio of drugs in development spanning traditional small molecules and biologics and the newer CGT operates with separate clinical supply organizations per these therapy areas. This is due to major differences throughout the clinical supply chain in both requirements and management practices.
XTalks
APRIL 6, 2023
IRT solutions help clinical trial sponsors meet the complexities of patient randomization and clinical supply management. He also shared how modern software development concepts are impacting IRT platforms and transforming the user experience in clinical trials. And you should expect that from your eClinical vendors.”
Pharmaceutical Technology
MARCH 20, 2023
They need to have that assistance of access to clinical trials.” Overcoming challenges with clinical trials in Africa Africa is made up of 54 countries, which potentially means 54 different sets of, not only rules and regulations for customs and operations, but also how they are interpreted on the ground.
XTalks
JUNE 16, 2023
XTALKS WEBINAR: Fostering Patient-Centricity: Clinical Supply Chain Strategies and Sourcing Solutions Live and On-Demand: Thursday, July 20, 2023, at 10am EDT (4pm CEST/EU-Central) Register for this free webinar to learn how to review clinical trial trends and supply strategies that impact the patient experience.
The Pharma Data
AUGUST 15, 2021
Food and Drug Administration (FDA) has granted Fast Track designation to VTX-801, Vivet’s clinical-stage gene therapy for the treatment of Wilson Disease – a rare, genetic disorder that reduces the ability of the liver and other tissues to regulate copper levels, causing severe hepatic damage, neurological symptoms, and potentially death.
Expert insights. Personalized for you.
59 
Let's personalize your content